Fasting hyperglycemia is associated with reduced hepatic insulin resistance and decreased first-phase insulin secretion, while elevated post-challenge glucose concentration is associated with peripheral insulin resistance and impairment of both early- and late-phase insulin response [35,36]. The gene discussed is INS; the disease is Hyperglycemia.